open access

Vol 7, No 6 (2011)
Review paper
Published online: 2012-02-27
Get Citation

Safety and efficacy of interferon-alfa2b (IFN) in the treatment of patients with mycosis fungoides

Ewa Chmielowska, Aleksandra Grzanka, Anna Krause, Maciej Studziński, Marcin Świeżyński, Kinga Lewandowska, Katarzyna Kalinowska, Jan Kopeć
Onkol. Prak. Klin 2011;7(6):301-310.

open access

Vol 7, No 6 (2011)
REVIEW ARTICLES
Published online: 2012-02-27

Abstract

This paper reports our own experience on interferon-alpha as the first-line systemic treatment of mycosis fungoides in the group of patients with advanced stages of disease after failure of skin-directed
therapies. Therapy resulted in improved quality of life and long-lasting, high response rate up to 80%. Given chronic character of MF special account must be taken not only to efficacy of the therapy, but also the safety.

Abstract

This paper reports our own experience on interferon-alpha as the first-line systemic treatment of mycosis fungoides in the group of patients with advanced stages of disease after failure of skin-directed
therapies. Therapy resulted in improved quality of life and long-lasting, high response rate up to 80%. Given chronic character of MF special account must be taken not only to efficacy of the therapy, but also the safety.
Get Citation

Keywords

mycosis fungoides, interferon, efficacy, quality of life

About this article
Title

Safety and efficacy of interferon-alfa2b (IFN) in the treatment of patients with mycosis fungoides

Journal

Oncology in Clinical Practice

Issue

Vol 7, No 6 (2011)

Article type

Review paper

Pages

301-310

Published online

2012-02-27

Bibliographic record

Onkol. Prak. Klin 2011;7(6):301-310.

Keywords

mycosis fungoides
interferon
efficacy
quality of life

Authors

Ewa Chmielowska
Aleksandra Grzanka
Anna Krause
Maciej Studziński
Marcin Świeżyński
Kinga Lewandowska
Katarzyna Kalinowska
Jan Kopeć

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl